2017
DOI: 10.1101/119461
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Profiling copy number variation and disease associations from 50,726 DiscovEHR Study exomes

Abstract: 21

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 29 publications
0
6
0
Order By: Relevance
“…The adult phenotype may not be well defined or may be unfamiliar to the adult physician. For example, a recent study of screening copy number variation in adults demonstrated that only one in 12 adults had been correctly diagnosed with the 22q11.2 deletion syndrome though 10 of 12 had clinical features consistent with the diagnosis (e.g., congenital heart defect, neurodevelopmental disorder) (Maxwell et al 2017). Phenotypic expression may also be subtler in adulthood, because of mosaicism or variable expressivity.…”
Section: Discussionmentioning
confidence: 99%
“…The adult phenotype may not be well defined or may be unfamiliar to the adult physician. For example, a recent study of screening copy number variation in adults demonstrated that only one in 12 adults had been correctly diagnosed with the 22q11.2 deletion syndrome though 10 of 12 had clinical features consistent with the diagnosis (e.g., congenital heart defect, neurodevelopmental disorder) (Maxwell et al 2017). Phenotypic expression may also be subtler in adulthood, because of mosaicism or variable expressivity.…”
Section: Discussionmentioning
confidence: 99%
“…Medically actionable exomes are now uncovering pathogenic or likely pathogenic variants in approximately 4% of these individuals. 8,9 Cost-effectiveness modeling suggests that returning a panel of secondary findings for $250 has an incremental cost-effectiveness ratio of <$50,000 for a 25-year-old individual. 10 This is within range of covered services, such as dialysis (incremental cost-effectiveness ratio, $129,000) 11 or mammography between the ages of 50 and 69 years (incremental costeffectiveness ratio, $29,000).…”
Section: Elective Genomic Testingmentioning
confidence: 99%
“…Although we cannot know the true family history of the deidentified individuals in our cohort, we have used PRIMUS 31 reconstructed pedigrees, ERSA distant-relationship estimates, and PADRE 37 to connect the pedigrees to identify the best pedigree representation of the mutation carriers of a tandem duplication in LDLR. 38 We used HumanOmniExpress array data (available for 25 out of the 37 carriers) to estimate the more distant relationships with the process described by Staples et. al.…”
Section: Pedigree Estimation Based On Distant Relationshipsmentioning
confidence: 99%
“…We attempted to perform visual validation of 23 high-confidence, 30 8). 38 The FH example is particularly interesting, given that we previously reported an FH-causing tandem duplication in LDLR [MIM: 606945]. 38 We have updated the CNV calls and found 37 carriers of the FH-causing tandem duplication among the 92K exomes, and we have reconstructed 30 out of the 37 carriers into a single extended pedigree.…”
Section: Compound Heterozygous Mutationsmentioning
confidence: 99%
See 1 more Smart Citation